BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3935638)

  • 1. Comparison of the antibacterial activity of azlocillin and ticarcillin in vitro and in irradiated neutropenic mice.
    van der Voet GB; Mattie H; van Furth R
    J Antimicrob Chemother; 1985 Nov; 16(5):605-13. PubMed ID: 3935638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of methodology in determining bactericidal and bacteriostatic activities of azlocillin and ticarcillin against Pseudomonas aeruginosa.
    Brumfitt W; Hamilton-Miller JM; Gooding A
    J Med Microbiol; 1984 Feb; 17(1):37-44. PubMed ID: 6420572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of anti-pseudomonas activity of azlocillin, mezlocillin, and ticarcillin.
    Coppens L; Klastersky J
    Antimicrob Agents Chemother; 1979 Mar; 15(3):396-9. PubMed ID: 111610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
    Machka K; Dickert H; Braveny I
    Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro comparison of N-formimidoyl thienamycin (MK0787) and Azlocillin with three aminoglycosides and ticarcillin against Pseudomonas aeruginosa.
    Matzkowitz AJ; Baltch AL; Smith RP; Sutphen NT; Hammer MC; Conroy JV
    Antimicrob Agents Chemother; 1982 Apr; 21(4):685-7. PubMed ID: 6805426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
    Chin NX; Jules K; Neu HC
    Eur J Clin Microbiol; 1986 Feb; 5(1):23-8. PubMed ID: 2938945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inoculum size on the activity of carboxy- and ureido-penicillins and effects of combinations of ureido-penicillins with aminoglycosides against resistant Pseudomonas aeruginosa.
    Watanakunakorn C
    J Antimicrob Chemother; 1986 Jan; 17(1):91-5. PubMed ID: 3081474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa.
    White AR; Comber KR; Sutherland R
    Antimicrob Agents Chemother; 1980 Jul; 18(1):182-9. PubMed ID: 6774663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative antibacterial activity of azlocillin, mezlocillin, carbenicillin and ticarcillin and relative stability to beta-lactamases of pseudomonas aeruginosa and klebsiella aerogenes.
    Basker MJ; Edmondson RA; Sutherland R
    Infection; 1979; 7(2):67-73. PubMed ID: 108220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy of azlocillin with aminoglycosides.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():33-8. PubMed ID: 6413482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Synergistic activity between ticarcillin, azlocillin, cefsulodin, ceftazidime and tobramycin or amikacin against Pseudomonas aeruginosa (author's transl)].
    Petit JC; Richard G; Burghoffer B; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):426-31. PubMed ID: 6810286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The response of Pseudomonas aeruginosa to azlocillin, ticarcillin and cefsulodin.
    Elliott TS; Greenwood D
    J Med Microbiol; 1983 Aug; 16(3):351-62. PubMed ID: 6410071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside.
    White GW; Malow JB; Zimelis VM; Pahlavanzadeh H; Panwalker AP; Jackson GG
    Antimicrob Agents Chemother; 1979 Apr; 15(4):540-3. PubMed ID: 111616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].
    Bauernfeind A; Petermüller C; Dietzel M
    Infection; 1979; 7(1):21-6. PubMed ID: 422252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.
    Gwynn MN; Rolinson GN
    Infection; 1980; 8(2):73-80. PubMed ID: 6771215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of piperacillin, ticarcillin, mezlocillin, ticarcillin-clavulanic acid, aztreonam, ceftazidime, azlocillin, cefoperazone, and thienamycin against Pseudomonas aeruginosa.
    Greenberg RN; Bollinger MR; Alivisatos MR
    Clin Ther; 1986; 8(6):655-7. PubMed ID: 3098426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative antibacterial effect of azlocillin, ticarcillin and carbenicillin on pseudomonas bacteria].
    Jotzoff M
    Med Welt; 1981 Sep; 32(39):1448-9. PubMed ID: 7300647
    [No Abstract]   [Full Text] [Related]  

  • 19. [Value of bactericidal curves in the optimal selection of a beta-lactam-aminoglycoside combination on Pseudomonas aeruginosa. In vitro study of 40 strains of Pseudomonas aeruginosa isolated in pediatric intensive care units].
    Lambert-Zechovsky N; Bingen E; Guihaire E; Nancy C; Mercier JC; Beaufils F
    Presse Med; 1986 Dec; 15(46):2309-12. PubMed ID: 2949273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of the inoculum effect on the MIC and MBC of 5 beta-lactams against Pseudomonas aeruginosa].
    Croize J; Le Noc P; Robert J
    Pathol Biol (Paris); 1984 May; 32(5):412-4. PubMed ID: 6429613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.